Armenia’s healthcare landscape is undergoing a significant transformation as cancer emerges as one of the country’s most pressing public health challenges. With rising incidence rates, an aging population, and increasing demand for modern therapies, the oncology sector is expanding rapidly. In this evolving environment, the presence of a reliable USFDA oncology manufacturer has become increasingly